INVESTOR PRESENTATION INVESTOR PRESENTATION June 2019 Strictly private and Confidential
DISCLAIMER This presentation has been prepared by Apollo industry results to differ materially from the results, of India (Issue of Capital and Disclosure Hospitals Enterprise Limited (“AHEL” or the Requirements) Regulations, 2009 as amended. financial condition, performance or achievements “Company”) solely for your information and for expressed or implied by such forward-looking your use and may not be taken away, distributed, No representation or warranty, express or implied, statements, including future changes or reproduced, or redistributed or passed on, directly is made as to, and no reliance should be placed on, developments in the Company’s business, its or indirectly, to any other person (whether within the fairness, accuracy, completeness or correctness competitive environment and political, economic, or outside your organization or firm) or published of the information or opinions contained in this legal and social conditions. Further, past in whole or in part, for any purpose by recipients presentation. Such information and opinions are in performance is not necessarily indicative of future directly or indirectly to any other person. By all events not current after the date of this results. Given these risks, uncertainties and other accessing this presentation, you are agreeing to be presentation. Certain statements made in this factors, viewers of this presentation are cautioned bound by the trailing restrictions and to maintain presentation may not be based on historical not to place undue reliance on these forward- absolute confidentiality regarding the information information or facts and may be “forward looking looking statements. The Company disclaims any disclosed in these materials. statements” based on the currently held beliefs obligation to update these forward-looking and assumptions of the management of the statements to reflect future events or This presentation does not constitute an offer or Company, which are expressed in good faith and in developments. invitation to purchase or subscribe for any their opinion reasonable, including those relating securities of the Company by any person in any to the Company’s general business plans and This presentation is for general information jurisdiction, including India and the United States. strategy, its future financial condition and growth purposes only, without regard to any specific No part of it should form the basis of or be relied prospects and future developments in its industry objectives, financial situations or informational upon in connection with any investment decision or and its competitive and regulatory environment. needs of any particular person. The Company may any contract or commitment to purchase or alter, modify or otherwise change in any manner subscribe for any securities. Securities may not be This presentation may contain statements that the content of this presentation, without obligation offered or sold in the United States absent constitute forward-looking statements. Forward- to notify any person of such change or changes. registration or an exemption from registration. This looking statements involve known and unknown This presentation may not be copied or presentation is not intended to be a prospectus (as risks, uncertainties and other factors, which may disseminated in any manner. defined under the Companies Act, 1956) or offer cause the actual results, financial condition, document under the Securities and Exchange Board performance or achievements of the Company or 2
KEY HIGHLIGHTS Leading private sector Attractive industry 01 02 healthcare services opportunity provider Strong operating & 03 04 Excellence in practice financial track record Anchored for the Well-Positioned to 05 06 Accelerate future 07 Strong management team 3
LEADING PRIVATE SECTOR 01 HEALTHCARE SERVICES PROVIDER 4
BUSINESS SNAPSHOT (1/2) AHLL & Other Healthcare Services Standalone Pharmacies Apollo Munich Businesses Health Insurance 54% * 40% 6% of Consolidated Revenues of Consolidated Revenues AHEL 10% stake of Consolidated Revenues • Gross Written Premium Primary Clinics – 104 Outlets 3496 Day surgery/ (GWP) of ` 4,866 Mn in Total Sugar Clinics – 27 Owned Managed Across 20 states CRADLE Q1FY20 10167 + + = BEDS 934 Dental Clinics – 66 8683 550 & 4 Union Territories • Assets under Management of Capacity Birthing centres – “CRADLE” - 12 ` 16,050 Mn as of Jun 19 Largest Pharmacy Chain in Day surgery/ Day Care Centres – 12 Total • 192 offices across the country Managed Owned India CRADLE Diagnostic Centres – 567 70 + + = 5 44 21 LOCATIONS Dialysis - 28 Capacity (Tertiary, Super Speciality & Secondary Care) Revenue Financial Year Number of Beds Pharmacy stores ( ` Mn) 2000 1500+ 25 2684 Employed + “Fee for Nurses Paramedics + + 2005 4000+ 170 6621 service” Doctors 12,000 + 5,000 + 10,000 + 2010 7900+ 1049 20265 2018 9800+ 3021 82435 8 23 JCI accreditation NABH accreditation 2019 10100+ 3428 96174 Source: Company audited Consolidated financials and Q4FY19 Earnings Update. Largest Hospital Network in India 5 Including proforma for Kolkata (50% holding), Delhi (22% holding) and Medics Lucknow (50%) whose Revenues are not consolidated under Ind AS due to joint control. •
BUSINESS SNAPSHOT (2/2) FY19 at Apollo Hospitals* High-end tertiary care practice contributes to 450,000+ 4,100,000+ 380,000+ 60% of Net revenues # Admissions Out-Patients Preventive Health Checks 6,500+ 10,000+ 30,000+ Cardiology Heart Surgeries Joint Neuro Surgical Replacements Discharges 22% Oncology Neuro Sciences 40% 900 1000 230 Robotic Surgeries Kidney Transplants Liver Transplants Orthopaedic 10% Gastroenterology 120 200+ 175,000+ 12% Countries Medical Bone Marrow Radiotherapy Others 6% 10% Value Travel Transplants Fractions 65,000+ Chemotherapy Cycles # FY 19 In-patient Revenues | Source: Company MIS reports * FY19 info for owned hospitals only. Does not include managed hospitals 6
PAN INDIA PRESENCE (1/2) Leading Hospital Players in India * Apollo Hospitals # of Beds: 10,167 **Fortis Hospitals India # of Hospitals: 70 Pan CARE Hospitals Apollo is the Columbia Asia # of Beds: 5,147 # of Beds: 2,241 # of Beds: 906 # of Hospitals: 28 leading player in # of Hospitals: 13 # of Hospitals: 11 the Indian Geographic Presence hospital segment Multiple Regions by geographic Narayana Hrudayalaya presence, HCG Aster DM Healthcare # of Beds: 7,155 # of Beds: 1,872 # of Beds: 4,340 business span # of Hospitals: 23 # of Hospitals: 24 # of Hospitals: 12 and breadth of Manipal Hospitals Region Shalby Hospitals Single service offerings. # of Beds: 2,012 # of Beds: 1,834 # of Hospitals: 9 # of Hospitals: 11 Single State Sterling Hospitals MAX Healthcare Medanta # of Beds: 1,805 # of Beds: 860 # of Beds: 2,604 # of Hospitals: 4 # of Hospitals: 14 # of Hospitals: 1 Source: Company Reports, CRISIL Research *Beds as on 30 th Jun 2019 ** Fortis presentation (Demerger of hospitals busn. of Narrow Business Span and Breadth of Services Wide Fortis into Manipal) as of March 2018, publicly 7 available on Fortis Healthcare Ltd.’s website
PAN INDIA PRESENCE (2/2) Details of beds under operation * Category wise Capacity Beds Operational Beds No. of Hospitals Bed Growth Owned Hospitals 8,683 7,246 44 Owned Beds Day care centres/ CRADLE 550 550 21 CAGR (FY05-19) 7.9% Managed Hospitals 934 934 5 Grand Total 10,167 8,730 70 Cluster wise (owned hospitals) 550 Chennai 1,696 1,511 11 Hyderabad 959 839 5 107 Kolkata 706 700 2 Delhi 790 715 2 Bangalore 627 556 3 Mumbai 478 225 1 8,683 Ahmedabad 320 263 2 7,145 Tamilnadu (outside Chennai) 808 650 6 5,376 Bhubaneswar 290 285 1 Other India 2,009 1,604 11 3,000 1,500 Grand Total 8,683 7,348 44 300 750 Maturity wise (owned hospitals) Mature ( > 10 years ) 4,931 4,548 23 FY90 FY95 FY00 FY05 FY10 FY15 FY19 5 – 10 years 1,029 926 8 0 – 5 years 2,723 1,874 13 Owned Cradle / Day care Grand Total 8,683 7,348 44 *Beds as on 30 th Jun 2019 8
ATTRACTIVE 02 INDUSTRY OPPORTUNITY 9
Recommend
More recommend
